To assess the efficacy of 24-week treatment with quetiapine in patients with schizophrenia or schizoaffective disorder
Study Type
OBSERVATIONAL
Enrollment
1,000
Research Site
Seoul, Dongdamoon-gu, South Korea
Research Site
Seoul, Kangnam-gu, South Korea
Research Site
Seoul, Songpa-gu, South Korea
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.